Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30000546 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1427212 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL29253334 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1427215 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1055870 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL140063 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1039992 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL140696 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL15048699 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL28614760 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118909698-A | Method for simultaneously extracting water-soluble and fat-soluble essential oil of peony | 三门峡牡仙生物科技有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-115768873-A | Viable cell constructs for biosynthesizing dairy products, and products and methods related thereto | 谢恩·吉利亚诺 | 2023-03-07 | — | — | CN | claimed |
| US-20230059978-A1 | LIVE CELL CONSTRUCTS FOR BIOSYNTHETIC MILK PRODUCTION AND RELATED PRODUCTS AND METHODS | GUILIANO SHAYNE (US) | 2023-02-23 | — | — | US | claimed |
| EP-4087915-A1 | LIVE CELL CONSTRUCTS FOR BIOSYNTHETIC MILK PRODUCTION AND RELATED PRODUCTS AND METHODS | Guiliano, Shayne (US) | 2022-11-16 | — | — | EP | claimed |
| WO-2021142241-A1 | LIVE CELL CONSTRUCTS FOR BIOSYNTHETIC MILK PRODUCTION AND RELATED PRODUCTS AND METHODS | GUILIANO SHAYNE (US) | 2021-07-15 | — | — | WO | claimed |
| CN-122055135-A | Cosmetic compositions and methods of use thereof | 玫琳凯有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20250345316-A1 | METHODS OF INCREASING LYMPHOCYTE TRAFFICKING TO THE COLON BY STIMULATING RETINOIC ACID RECEPTORS AND ARYL HYDROCARBON RECEPTORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250235422-A1 | DODECA-2,4,6,8,10-PENTAENOIC ACID COMPOSITIONS AND USES THEREOF | BIOMEDIT, INC. | 2025-07-24 | — | — | US | disclosed |
| CN-120051283-A | Nutraceutical compositions and methods of use thereof | 玫琳凯有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119724395-A | Oxidized fatty acid scale qualitative method based on non-targeted metabonomics | 中国科学院大连化学物理研究所 | 2025-03-28 | — | — | CN | disclosed |
| CN-118909698-A | Method for simultaneously extracting water-soluble and fat-soluble essential oil of peony | 三门峡牡仙生物科技有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-117849324-A | Metabolism marker combination related to fight aggressive behavior, detection reagent and application | 河南农业大学 | 2024-04-09 | — | — | CN | disclosed |
| WO-1999030620-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| EP-0901793-A1 | Thermal preactivation of gaseous precursor filled compositions | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-17 | — | — | EP | disclosed |
| WO-1998050040-A1 | NOVEL LIPID SOLUBLE STEROID PRODRUGS | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998050041-A1 | NOVEL PRODRUGS COMPRISING FLUORINATED AMPHIPHILES | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998048838-A1 | COMPOUNDS | NYCOMED IMAGING AS (NO) | 1998-11-05 | — | — | WO | disclosed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250235422-A1 | DODECA-2,4,6,8,10-PENTAENOIC ACID COMPOSITIONS AND USES THEREOF | CUTA, ALOX5AP, DAGLA | FASN 626/4885ALDH1A1 616/4885TSHR 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.